Medline discussing upsizing IPO, unlikely to price at high end: Source

We are getting some news on the IPO front. Our Leslie Picker joins us now with the very latest. Hey Les. >> Hey Scott.Yeah, I wanted to give you an update on the Medline IPO. I am told that bankers, the sponsors, the company are currently huddled together discussing pricing options for this deal. I am told that they're considering and discussing potentially upsizing the offering.However, at this point in time, they are unlikely to price at the high end, that $30, uh, that high end of the range that they had ...